NASDAQ: NKGN

NKGen Biotech (NASDAQ: NKGN) stock soared over 50% in intraday trading Monday following an update on its Phase 2 clinical […]

NKGen Biotech (NASDAQ: NKGN) stock more than doubled on Wednesday amidst a lack of evident catalysts or company-specific news. NKGen